IBO insider buying and SEC filings, explained
Impact Biomedical Inc. · CIK 1834105
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- NYSE
- Industry (SIC)
- Pharmaceutical Preparations
- State of incorporation
- NV
- Fiscal year end
- Dec 31
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$148K
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Sep 22–24, 2026 | Sale | DSS, INC. (10% owner) sold 906 shares between Sep 22 and Sep 24 at about $1.86 ($2K). Holdings down <1% to 589,518 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Sep 24, 2026 |
| Mar 25–27, 2026 | Sale | Todd D Macko (CFO) sold 45,000 shares between Mar 25 and Mar 27 at about $0.5614 ($25K). Holdings down 22% to 155,122 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 30, 2026 |
| Mar 23, 2026 | Sale | Jason Grady (Director) sold 50,000 shares at $0.6500 ($33K). Holdings down 17% to 250,182 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 25, 2026 |
| May 22–27, 2025 | Sale | DSS, INC. (10% owner) sold 161,000 shares between May 22, 2025 and May 27, 2025 at about $0.5472 ($88K). Holdings down 23% to 545,024 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jan 6, 2026 |
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
| Filed | Items | Tag | Source |
|---|---|---|---|
| Nov 3, 2026, 9:15 AM ET 8-K | Reg FD disclosure (Item 7.01) | SEC filing |
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow IBO in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.